These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

702 related articles for article (PubMed ID: 27597739)

  • 41. lncRNA MEG3 inhibits the growth of hepatocellular carcinoma cells by sponging miR-9-5p to upregulate SOX11.
    Liu Z; Chen JY; Zhong Y; Xie L; Li JS
    Braz J Med Biol Res; 2019; 52(10):e8631. PubMed ID: 31531526
    [TBL] [Abstract][Full Text] [Related]  

  • 42. LncRNA DANCR promotes cervical cancer progression by upregulating ROCK1 via sponging miR-335-5p.
    Liang H; Zhang C; Guan H; Liu J; Cui Y
    J Cell Physiol; 2019 May; 234(5):7266-7278. PubMed ID: 30362591
    [TBL] [Abstract][Full Text] [Related]  

  • 43. XIST Induced by JPX Suppresses Hepatocellular Carcinoma by Sponging miR-155-5p.
    Lin XQ; Huang ZM; Chen X; Wu F; Wu W
    Yonsei Med J; 2018 Sep; 59(7):816-826. PubMed ID: 30091314
    [TBL] [Abstract][Full Text] [Related]  

  • 44. LncRNA MYLK-AS1 facilitates tumor progression and angiogenesis by targeting miR-424-5p/E2F7 axis and activating VEGFR-2 signaling pathway in hepatocellular carcinoma.
    Teng F; Zhang JX; Chang QM; Wu XB; Tang WG; Wang JF; Feng JF; Zhang ZP; Hu ZQ
    J Exp Clin Cancer Res; 2020 Nov; 39(1):235. PubMed ID: 33168027
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Long noncoding RNA BLACAT1 is overexpressed in hepatocellular carcinoma and its downregulation suppressed cancer cell development through endogenously competing against hsa-miR-485-5p.
    Peng Y; Leng W; Duan S; Hong M
    Biomed Pharmacother; 2019 Aug; 116():109027. PubMed ID: 31174090
    [TBL] [Abstract][Full Text] [Related]  

  • 46. CircRNA-104718 acts as competing endogenous RNA and promotes hepatocellular carcinoma progression through microRNA-218-5p/TXNDC5 signaling pathway.
    Yu J; Yang M; Zhou B; Luo J; Zhang Z; Zhang W; Yan Z
    Clin Sci (Lond); 2019 Jul; 133(13):1487-1503. PubMed ID: 31278132
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Long non-coding RNA MNX1-AS1 promotes hepatocellular carcinoma proliferation and invasion through targeting miR-218-5p/COMMD8 axis.
    Ji D; Wang Y; Sun B; Yang J; Luo X
    Biochem Biophys Res Commun; 2019 Jun; 513(3):669-674. PubMed ID: 30982576
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Long noncoding RNA GIHCG promotes hepatocellular carcinoma progression through epigenetically regulating miR-200b/a/429.
    Sui CJ; Zhou YM; Shen WF; Dai BH; Lu JJ; Zhang MF; Yang JM
    J Mol Med (Berl); 2016 Nov; 94(11):1281-1296. PubMed ID: 27380494
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hepatitis B virus X protein related lncRNA WEE2-AS1 promotes hepatocellular carcinoma proliferation and invasion.
    Hu Z; Huang P; Yan Y; Zhou Z; Wang J; Wu G
    Biochem Biophys Res Commun; 2019 Jan; 508(1):79-86. PubMed ID: 30471857
    [TBL] [Abstract][Full Text] [Related]  

  • 50. lncRNA A1BG-AS1 suppresses proliferation and invasion of hepatocellular carcinoma cells by targeting miR-216a-5p.
    Bai J; Yao B; Wang L; Sun L; Chen T; Liu R; Yin G; Xu Q; Yang W
    J Cell Biochem; 2019 Jun; 120(6):10310-10322. PubMed ID: 30556161
    [TBL] [Abstract][Full Text] [Related]  

  • 51. LINC00922 promotes the proliferation, migration, invasion and EMT process of liver cancer cells by regulating miR-424-5p/ARK5.
    Ye Z; He Q; Wang Q; Lin Y; Cen K; Chen X
    Mol Cell Biochem; 2021 Oct; 476(10):3757-3769. PubMed ID: 34097192
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long non-coding RNA AOC4P suppresses hepatocellular carcinoma metastasis by enhancing vimentin degradation and inhibiting epithelial-mesenchymal transition.
    Wang TH; Lin YS; Chen Y; Yeh CT; Huang YL; Hsieh TH; Shieh TM; Hsueh C; Chen TC
    Oncotarget; 2015 Sep; 6(27):23342-57. PubMed ID: 26160837
    [TBL] [Abstract][Full Text] [Related]  

  • 53. miR-139-5p inhibits epithelial-mesenchymal transition, migration and invasion of hepatocellular carcinoma cells by targeting ZEB1 and ZEB2.
    Qiu G; Lin Y; Zhang H; Wu D
    Biochem Biophys Res Commun; 2015 Jul; 463(3):315-21. PubMed ID: 26022123
    [TBL] [Abstract][Full Text] [Related]  

  • 54. LncRNA SNAI3-AS1 promotes PEG10-mediated proliferation and metastasis via decoying of miR-27a-3p and miR-34a-5p in hepatocellular carcinoma.
    Li Y; Guo D; Lu G; Mohiuddin Chowdhury ATM; Zhang D; Ren M; Chen Y; Wang R; He S
    Cell Death Dis; 2020 Aug; 11(8):685. PubMed ID: 32826862
    [TBL] [Abstract][Full Text] [Related]  

  • 55. LncRNA PCNAP1 modulates hepatitis B virus replication and enhances tumor growth of liver cancer.
    Feng J; Yang G; Liu Y; Gao Y; Zhao M; Bu Y; Yuan H; Yuan Y; Yun H; Sun M; Gao H; Zhang S; Liu Z; Yin M; Song X; Miao Z; Lin Z; Zhang X
    Theranostics; 2019; 9(18):5227-5245. PubMed ID: 31410212
    [No Abstract]   [Full Text] [Related]  

  • 56. LncRNA DGCR5 represses the development of hepatocellular carcinoma by targeting the miR-346/KLF14 axis.
    Wang YG; Liu J; Shi M; Chen FX
    J Cell Physiol; 2018 Jan; 234(1):572-580. PubMed ID: 30216442
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long non-coding RNA LINC00461/miR-149-5p/LRIG2 axis regulates hepatocellular carcinoma progression.
    Ji D; Wang Y; Li H; Sun B; Luo X
    Biochem Biophys Res Commun; 2019 Apr; 512(2):176-181. PubMed ID: 30879766
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Candidate lncRNA-miRNA-mRNA network in predicting hepatocarcinogenesis with cirrhosis: an integrated bioinformatics analysis.
    Zhang R; Jiang YY; Xiao K; Huang XQ; Wang J; Chen SY
    J Cancer Res Clin Oncol; 2020 Jan; 146(1):87-96. PubMed ID: 31758243
    [TBL] [Abstract][Full Text] [Related]  

  • 59. LINC00205 promotes proliferation, migration and invasion of HCC cells by targeting miR-122-5p.
    Zhang L; Wang Y; Sun J; Ma H; Guo C
    Pathol Res Pract; 2019 Sep; 215(9):152515. PubMed ID: 31272761
    [TBL] [Abstract][Full Text] [Related]  

  • 60. LncRNA SNHG3 Promotes Hepatocellular Tumorigenesis by Targeting miR-326.
    Zhao Q; Wu C; Wang J; Li X; Fan Y; Gao S; Wang K
    Tohoku J Exp Med; 2019 Sep; 249(1):43-56. PubMed ID: 31548493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.